By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Hythiam, Inc. 

11111 Santa Monica Boulevard, Suite 550

Los Angeles  California  90025  U.S.A.
Phone: 310-268-0011 Fax: 310-268-0012


SEARCH JOBS


Industry
Biotechnology

Segment
Research





Company News
Hythiam, Inc. Announces Peer-Reviewed Publication of Randomized, Double-Blind, Placebo-Controlled Study 2/10/2010 9:52:56 AM
Hythiam, Inc. CEO Interviewed on CorporateProfile.com 1/29/2010 12:03:32 PM
Hythiam, Inc. Announces Publication on Predictive Modeling for Substance Dependent Populations in Perspectives in Health Information Management 1/13/2010 9:34:27 AM
Hythiam, Inc. Announces First Peer-Reviewed Publication of Statistically Significant Results from Randomized, Double-Blind, Placebo-Controlled Study 9/28/2009 10:09:10 AM
Hythiam, Inc. Announces Fourth Quarter and 2008 Year-End Results 4/1/2009 11:19:43 AM
Hythiam, Inc. Announces Results of Two Double-Blind, Placebo-Controlled Studies on Impact of PROMETA(R) Treatment Program for Alcohol Dependence 3/26/2009 9:42:44 AM
Research Provides Further Evidence for the Mechanism of Action Underlying Hythiam, Inc.’s PROMETA(R) Treatment Program 11/18/2008 9:52:00 AM
Double-Blind, Placebo-Controlled Alcohol Study of Hythiam, Inc.'s Prometa Treatment Program Demonstrated Statistically Significant Improvement in Patients with Symptoms of Alcohol Withdrawal 7/8/2008 9:15:08 AM
Intent-to-Treat Analysis of Double-Blind Methamphetamine Study Confirms Hythiam, Inc.'s PROMETA Treatment Program Showed Statistically Significant Reduction in Cravings Compared to Placebo 6/19/2008 9:04:08 AM
Russian Patent Office Provides Notification of Intention to Grant Hythiam, Inc. Patent for Treatment of Cocaine Dependence 11/5/2007 11:14:27 AM
123
//-->